$IMLFF attracting highly qualified and extensively experienced biotech and pharmaceutical professionals to both the Management Team and the Board of Directors in 2016. Ms. Alex Mancini, our Sr. VP of Clinical & Regulatory Affairs, has already been very instrumental in solidifying the INM-750 development plan for epidermolysis bullosa (EB) and will continue to direct her efforts primarily towards executing on this program.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.